×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs ...
PR Newswire
NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this...
11 hours ago
NRx antidepressant fails to reduce depression severity
Fierce Biotech
NRx Pharmaceuticals' investigational antidepressant has failed to reach statistical significance in reducing depression severity in a phase...
9 hours ago
Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study - NRX Pharmaceuticals ...
Benzinga
NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.
8 hours ago
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
Yahoo Finance
The latest trading day saw NRx Pharmaceuticals, Inc. (NRXP) settling at $3.14, representing a +0.64% change from its previous close.
5 days ago
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
PR Newswire
The reverse stock split will become effective at 4:30 p.m. Eastern Time on Monday, April 1, 2024. The Company's common stock will continue to be...
1 month ago
NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know
Yahoo Finance
NRx Pharmaceuticals (NRXP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks...
4 weeks ago
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated ...
PR Newswire
PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals", "NRx", the "Company"), a clinical-stage biopharmaceutical...
2 weeks ago
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
PR Newswire
PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical...
2 weeks ago
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
PR Newswire
PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company,...
2 weeks ago
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment ...
PR Newswire
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of...
3 weeks ago